Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Sernova Corp > Rigby will give a huge boost to SVA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(71)
•••
Comment by on-targeton May 28, 2024 9:38am
123 Views
Post# 36060103

RE:Rigby will give a huge boost to SVA

RE:Rigby will give a huge boost to SVA    Mr. Rigby served as the CEO for SteadyMed Therapeutics (NASDAQ:STDY), which he listed on Nasdaq prior to its acquisition by United Therapeutics (NASDAQ:UTHR), and was co-founder of Zogenix (NASDAQ:ZGNX), which was also acquired by UCB (Euronext:UCB) after completing a NASDAQ listing. 

https://www.thenewswire.com/press-releases/1kogFawZq-sernova-appoints-jonathan-rigby-to-its-board-of-directors.html#:~:text=%E2%80%9CWe%20are%20excited%20to%20welcome,biotech%20CEO%20and%20Board%20member.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities